

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 6.53115970 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.53115970 |
| 3 | cellular response to interleukin-15 (GO:0071350) | 5.55857031 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.36416460 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.15351922 |
| 6 | response to interleukin-15 (GO:0070672) | 5.06854985 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.92246514 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.73900485 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.69535322 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.60487356 |
| 11 | T cell migration (GO:0072678) | 4.57764360 |
| 12 | positive thymic T cell selection (GO:0045059) | 4.51063924 |
| 13 | thymic T cell selection (GO:0045061) | 4.42260583 |
| 14 | negative T cell selection (GO:0043383) | 4.36798964 |
| 15 | negative thymic T cell selection (GO:0045060) | 4.36599610 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.34256395 |
| 17 | L-serine metabolic process (GO:0006563) | 4.34026067 |
| 18 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.31122766 |
| 19 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.27941265 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.27707669 |
| 21 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.19763562 |
| 22 | chronic inflammatory response (GO:0002544) | 3.94803556 |
| 23 | serine family amino acid biosynthetic process (GO:0009070) | 3.93883130 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.93410128 |
| 25 | tolerance induction (GO:0002507) | 3.88585636 |
| 26 | cytidine metabolic process (GO:0046087) | 3.88578846 |
| 27 | cytidine catabolic process (GO:0006216) | 3.88578846 |
| 28 | cytidine deamination (GO:0009972) | 3.88578846 |
| 29 | folic acid metabolic process (GO:0046655) | 3.85482365 |
| 30 | leukocyte aggregation (GO:0070486) | 3.80440920 |
| 31 | regulation of memory T cell differentiation (GO:0043380) | 3.78219549 |
| 32 | regulation of activation of Janus kinase activity (GO:0010533) | 3.77942924 |
| 33 | folic acid transport (GO:0015884) | 3.68397717 |
| 34 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.65151169 |
| 35 | positive T cell selection (GO:0043368) | 3.61778548 |
| 36 | T cell selection (GO:0045058) | 3.58899939 |
| 37 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.55722160 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.54336455 |
| 39 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.53535644 |
| 40 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.53535644 |
| 41 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.52292316 |
| 42 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.51739039 |
| 43 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.48208778 |
| 44 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.47538011 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 3.46444471 |
| 46 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.44581758 |
| 47 | negative regulation of innate immune response (GO:0045824) | 3.40833735 |
| 48 | lymphocyte migration (GO:0072676) | 3.40667672 |
| 49 | glycine metabolic process (GO:0006544) | 3.35174132 |
| 50 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.32519850 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.30035936 |
| 52 | proteasome assembly (GO:0043248) | 3.29591768 |
| 53 | regulation of cell killing (GO:0031341) | 3.27477632 |
| 54 | lymphocyte chemotaxis (GO:0048247) | 3.24500975 |
| 55 | heme transport (GO:0015886) | 3.24236718 |
| 56 | positive regulation of interleukin-17 production (GO:0032740) | 3.23130297 |
| 57 | type I interferon signaling pathway (GO:0060337) | 3.22778324 |
| 58 | cellular response to type I interferon (GO:0071357) | 3.22778324 |
| 59 | response to type I interferon (GO:0034340) | 3.19787716 |
| 60 | skin morphogenesis (GO:0043589) | 3.19401232 |
| 61 | positive regulation of cell killing (GO:0031343) | 3.19093778 |
| 62 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18946174 |
| 63 | L-phenylalanine metabolic process (GO:0006558) | 3.18449019 |
| 64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.18449019 |
| 65 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.17826503 |
| 66 | creatine metabolic process (GO:0006600) | 3.17401303 |
| 67 | dendritic cell chemotaxis (GO:0002407) | 3.15535505 |
| 68 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.14412549 |
| 69 | positive regulation of T cell mediated immunity (GO:0002711) | 3.13423797 |
| 70 | L-methionine salvage (GO:0071267) | 3.12532405 |
| 71 | L-methionine biosynthetic process (GO:0071265) | 3.12532405 |
| 72 | amino acid salvage (GO:0043102) | 3.12532405 |
| 73 | serine family amino acid metabolic process (GO:0009069) | 3.08662887 |
| 74 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.06143544 |
| 75 | NIK/NF-kappaB signaling (GO:0038061) | 3.05099470 |
| 76 | positive regulation of defense response to virus by host (GO:0002230) | 3.03928833 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 3.03083620 |
| 78 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00275275 |
| 79 | T cell receptor signaling pathway (GO:0050852) | 2.97269323 |
| 80 | regulation of T cell mediated immunity (GO:0002709) | 2.96909925 |
| 81 | peptidyl-proline hydroxylation (GO:0019511) | 2.96424674 |
| 82 | response to muramyl dipeptide (GO:0032495) | 2.94930027 |
| 83 | ribosome assembly (GO:0042255) | 2.94315627 |
| 84 | eosinophil chemotaxis (GO:0048245) | 2.94306580 |
| 85 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.92312649 |
| 86 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.90835278 |
| 87 | cellular defense response (GO:0006968) | 2.89634989 |
| 88 | positive regulation of tolerance induction (GO:0002645) | 2.89436895 |
| 89 | serine family amino acid catabolic process (GO:0009071) | 2.89373923 |
| 90 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.88359462 |
| 91 | regulation of tolerance induction (GO:0002643) | 2.87729147 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.87650159 |
| 93 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.87267333 |
| 94 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.87024904 |
| 95 | negative regulation of fibrinolysis (GO:0051918) | 2.86275096 |
| 96 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.85884168 |
| 97 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.85777190 |
| 98 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.85414903 |
| 99 | glyoxylate metabolic process (GO:0046487) | 2.84641917 |
| 100 | epoxygenase P450 pathway (GO:0019373) | 2.84437306 |
| 101 | 4-hydroxyproline metabolic process (GO:0019471) | 2.83123380 |
| 102 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.82741664 |
| 103 | L-phenylalanine catabolic process (GO:0006559) | 2.82741664 |
| 104 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.81355859 |
| 105 | protein heterotrimerization (GO:0070208) | 2.80394264 |
| 106 | regulation of T-helper 1 type immune response (GO:0002825) | 2.80185779 |
| 107 | mast cell activation (GO:0045576) | 2.78389678 |
| 108 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.78337092 |
| 109 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.77188508 |
| 110 | muscle filament sliding (GO:0030049) | 2.76229070 |
| 111 | actin-myosin filament sliding (GO:0033275) | 2.76229070 |
| 112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.75246720 |
| 113 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.74988450 |
| 114 | positive regulation of interleukin-4 production (GO:0032753) | 2.74578822 |
| 115 | negative regulation of T cell apoptotic process (GO:0070233) | 2.73167136 |
| 116 | regulation of alpha-beta T cell activation (GO:0046634) | 2.72644398 |
| 117 | negative regulation of type 2 immune response (GO:0002829) | 2.70274424 |
| 118 | lymph node development (GO:0048535) | 2.68707904 |
| 119 | protein carboxylation (GO:0018214) | 2.68620056 |
| 120 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.68620056 |
| 121 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.68543741 |
| 122 | collagen fibril organization (GO:0030199) | 2.66883704 |
| 123 | low-density lipoprotein particle clearance (GO:0034383) | 2.66474005 |
| 124 | regulation of B cell differentiation (GO:0045577) | 2.65756834 |
| 125 | regulation of T cell chemotaxis (GO:0010819) | 2.65689881 |
| 126 | positive regulation of T cell chemotaxis (GO:0010820) | 2.65689881 |
| 127 | leukocyte degranulation (GO:0043299) | 2.65371036 |
| 128 | sulfur amino acid biosynthetic process (GO:0000097) | 2.65117050 |
| 129 | formation of translation preinitiation complex (GO:0001731) | 2.64830810 |
| 130 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.64828801 |
| 131 | regulation of defense response to virus by host (GO:0050691) | 2.64821536 |
| 132 | AMP metabolic process (GO:0046033) | 2.64690985 |
| 133 | T cell costimulation (GO:0031295) | 2.64131360 |
| 134 | immunoglobulin mediated immune response (GO:0016064) | 2.63142414 |
| 135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.62213446 |
| 136 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.60089050 |
| 137 | T-helper cell differentiation (GO:0042093) | 2.60089050 |
| 138 | oxygen transport (GO:0015671) | 2.60013308 |
| 139 | cranial suture morphogenesis (GO:0060363) | 2.59941304 |
| 140 | amino-acid betaine metabolic process (GO:0006577) | 2.59758604 |
| 141 | endodermal cell differentiation (GO:0035987) | 2.59725067 |
| 142 | lymphocyte costimulation (GO:0031294) | 2.59700930 |
| 143 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.59398948 |
| 144 | regulation of defense response to virus by virus (GO:0050690) | 2.59301098 |
| 145 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.59120135 |
| 146 | alpha-linolenic acid metabolic process (GO:0036109) | 2.58588314 |
| 147 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.58189940 |
| 148 | branched-chain amino acid catabolic process (GO:0009083) | 2.58028828 |
| 149 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.57433606 |
| 150 | epithelial cell-cell adhesion (GO:0090136) | 2.56721262 |
| 151 | modified amino acid transport (GO:0072337) | 2.51510407 |
| 152 | cysteine metabolic process (GO:0006534) | 2.51106370 |
| 153 | purine nucleobase biosynthetic process (GO:0009113) | 2.51074177 |
| 154 | eosinophil migration (GO:0072677) | 2.50083225 |
| 155 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.46783903 |
| 156 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.46696529 |
| 157 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.46118849 |
| 158 | aspartate family amino acid metabolic process (GO:0009066) | 2.46068300 |
| 159 | homocysteine metabolic process (GO:0050667) | 2.43543501 |
| 160 | alpha-amino acid biosynthetic process (GO:1901607) | 2.43177032 |
| 161 | methionine biosynthetic process (GO:0009086) | 2.40973581 |
| 162 | regulation of protein activation cascade (GO:2000257) | 2.40125170 |
| 163 | regulation of complement activation (GO:0030449) | 2.39818154 |
| 164 | folic acid-containing compound metabolic process (GO:0006760) | 2.39536361 |
| 165 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.39216789 |
| 166 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.39216789 |
| 167 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.39144138 |
| 168 | extracellular matrix assembly (GO:0085029) | 2.38630107 |
| 169 | regulation of plasminogen activation (GO:0010755) | 2.38265528 |
| 170 | acetyl-CoA metabolic process (GO:0006084) | 2.37126595 |
| 171 | protein hydroxylation (GO:0018126) | 2.35959706 |
| 172 | bone trabecula formation (GO:0060346) | 2.33963590 |
| 173 | sulfur amino acid metabolic process (GO:0000096) | 2.32626666 |
| 174 | regulation of metalloenzyme activity (GO:0048552) | 2.32388244 |
| 175 | endothelial cell morphogenesis (GO:0001886) | 2.31092160 |
| 176 | cofactor transport (GO:0051181) | 2.30315449 |
| 177 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.30294195 |
| 178 | branched-chain amino acid metabolic process (GO:0009081) | 2.29661725 |
| 179 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.29589150 |
| 180 | biotin metabolic process (GO:0006768) | 2.29046793 |
| 181 | lung-associated mesenchyme development (GO:0060484) | 2.28665775 |
| 182 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.28067379 |
| 183 | interferon-gamma secretion (GO:0072643) | 2.27979392 |
| 184 | chondrocyte proliferation (GO:0035988) | 2.27221773 |
| 185 | regulation of triglyceride catabolic process (GO:0010896) | 2.27156876 |
| 186 | COPII vesicle coating (GO:0048208) | 2.24940536 |
| 187 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.24904496 |
| 188 | lysine metabolic process (GO:0006553) | 2.22847479 |
| 189 | lysine catabolic process (GO:0006554) | 2.22847479 |
| 190 | nucleobase biosynthetic process (GO:0046112) | 2.20054203 |
| 191 | gap junction assembly (GO:0016264) | 2.19884194 |
| 192 | regulation of cholesterol homeostasis (GO:2000188) | 2.19759179 |
| 193 | methionine metabolic process (GO:0006555) | 2.19649216 |
| 194 | regulation of fibrinolysis (GO:0051917) | 2.18826697 |
| 195 | fatty acid beta-oxidation (GO:0006635) | 2.18795793 |
| 196 | fibrinolysis (GO:0042730) | 2.18721945 |
| 197 | galactose catabolic process (GO:0019388) | 2.18219366 |
| 198 | positive regulation of extracellular matrix organization (GO:1903055) | 2.17399590 |
| 199 | ADP metabolic process (GO:0046031) | 2.17376431 |
| 200 | plasma lipoprotein particle clearance (GO:0034381) | 2.14559086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.10448496 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82472648 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.81832363 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81728036 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.74402389 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.28227133 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.23549274 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.20801444 |
| 9 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.12004231 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.05927438 |
| 11 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.81556143 |
| 12 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.69034635 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.59758993 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.57345665 |
| 15 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.54898848 |
| 16 | * MAF_26560356_Chip-Seq_TH1_Human | 2.49081542 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.48558768 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.46465831 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45474772 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.45262623 |
| 21 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.43001531 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.28690295 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.27524047 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.26066134 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.23680127 |
| 26 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.20548287 |
| 27 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.16535298 |
| 28 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.16248409 |
| 29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.11213514 |
| 30 | * MAF_26560356_Chip-Seq_TH2_Human | 2.11071494 |
| 31 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.09463007 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.07756740 |
| 33 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05592905 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.04647793 |
| 35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.02730421 |
| 36 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.01552187 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.01006601 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98680353 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98034737 |
| 40 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90535973 |
| 41 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.89935758 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.89616967 |
| 43 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.88149640 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87356605 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.84769314 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83847247 |
| 47 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.83163910 |
| 48 | MYB_26560356_Chip-Seq_TH1_Human | 1.82765917 |
| 49 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.82598659 |
| 50 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.82598659 |
| 51 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.82598659 |
| 52 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81860160 |
| 53 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.80333866 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80027159 |
| 55 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.78472340 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.78202332 |
| 57 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.76523584 |
| 58 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.76424630 |
| 59 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.76420989 |
| 60 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72701988 |
| 61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71706614 |
| 62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70261486 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69201644 |
| 64 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.67298019 |
| 65 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.64686829 |
| 66 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.64045620 |
| 67 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.62771658 |
| 68 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60933423 |
| 69 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.58649573 |
| 70 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.58130315 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.56721118 |
| 72 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.56098513 |
| 73 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.55861643 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53533497 |
| 75 | ATF3_27146783_Chip-Seq_COLON_Human | 1.53046009 |
| 76 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.52815205 |
| 77 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.51895331 |
| 78 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.51330729 |
| 79 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.50607495 |
| 80 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48001626 |
| 81 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.47379974 |
| 82 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46934653 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.46708704 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.46420671 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46154214 |
| 86 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.44446943 |
| 87 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.44237272 |
| 88 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.44022877 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.43525784 |
| 90 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.42961536 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41994705 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 1.41872142 |
| 93 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.41779904 |
| 94 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.41759812 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.41416267 |
| 96 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40949188 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40936704 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.40178641 |
| 99 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39962255 |
| 100 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.38280090 |
| 101 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37104157 |
| 102 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36997981 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.36247861 |
| 104 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.36225787 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35839094 |
| 106 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.35284897 |
| 107 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.33623956 |
| 108 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.32546486 |
| 109 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32178476 |
| 110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31668090 |
| 111 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.30774973 |
| 112 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30732912 |
| 113 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28910173 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.28650368 |
| 115 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.28034312 |
| 116 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.26347751 |
| 117 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.25830134 |
| 118 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.25219039 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24415608 |
| 120 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.24308415 |
| 121 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23328712 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23236648 |
| 123 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23072773 |
| 124 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21934769 |
| 125 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.21116562 |
| 126 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.20915378 |
| 127 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.20763957 |
| 128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19713944 |
| 129 | SA1_27219007_Chip-Seq_Bcells_Human | 1.17700459 |
| 130 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16974991 |
| 131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16387213 |
| 132 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.16258493 |
| 133 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16048491 |
| 134 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14991231 |
| 135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14762079 |
| 136 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14403292 |
| 137 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13136182 |
| 138 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12677744 |
| 139 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12310242 |
| 140 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.12039123 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11988417 |
| 142 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11748847 |
| 143 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10642168 |
| 144 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10267812 |
| 145 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09891511 |
| 146 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09636017 |
| 147 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09522124 |
| 148 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.08557987 |
| 149 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06626103 |
| 150 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05141548 |
| 151 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02476215 |
| 152 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02354189 |
| 153 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.02157058 |
| 154 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01890010 |
| 155 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01723028 |
| 156 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99545767 |
| 157 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98994083 |
| 158 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98843680 |
| 159 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.98768402 |
| 160 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98518516 |
| 161 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98101195 |
| 162 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98023362 |
| 163 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.96889681 |
| 164 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.96243553 |
| 165 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.96090954 |
| 166 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96078404 |
| 167 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95786862 |
| 168 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95786862 |
| 169 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95690101 |
| 170 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94709504 |
| 171 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94239634 |
| 172 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93744672 |
| 173 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.93592674 |
| 174 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91949890 |
| 175 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.90919304 |
| 176 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.90889357 |
| 177 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.90603601 |
| 178 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.89993831 |
| 179 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.89274133 |
| 180 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.88067976 |
| 181 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.87775466 |
| 182 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87025650 |
| 183 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.86286079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.17852125 |
| 2 | MP0005671_abnormal_response_to | 4.22093761 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.89770672 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.63666956 |
| 5 | MP0003436_decreased_susceptibility_to | 3.42956685 |
| 6 | MP0003724_increased_susceptibility_to | 3.37072585 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.17474804 |
| 8 | MP0009840_abnormal_foam_cell | 3.04464238 |
| 9 | MP0005275_abnormal_skin_tensile | 3.02064929 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.81046468 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.70745914 |
| 12 | MP0005503_abnormal_tendon_morphology | 2.62555768 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.58720671 |
| 14 | MP0009785_altered_susceptibility_to | 2.52395316 |
| 15 | MP0000685_abnormal_immune_system | 2.47821365 |
| 16 | MP0001800_abnormal_humoral_immune | 2.46565591 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.41452038 |
| 18 | MP0005360_urolithiasis | 2.39919577 |
| 19 | MP0002723_abnormal_immune_serum | 2.36574388 |
| 20 | MP0005025_abnormal_response_to | 2.34865332 |
| 21 | MP0001790_abnormal_immune_system | 2.30406139 |
| 22 | MP0005387_immune_system_phenotype | 2.30406139 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.20583137 |
| 24 | MP0001819_abnormal_immune_cell | 2.19503350 |
| 25 | MP0003279_aneurysm | 2.19286726 |
| 26 | MP0005023_abnormal_wound_healing | 2.18994414 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 2.16485939 |
| 28 | MP0002419_abnormal_innate_immunity | 2.11450040 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.06201837 |
| 30 | MP0006082_CNS_inflammation | 2.05838010 |
| 31 | MP0005623_abnormal_meninges_morphology | 2.03639336 |
| 32 | MP0009384_cardiac_valve_regurgitation | 2.02232787 |
| 33 | MP0001542_abnormal_bone_strength | 1.97354876 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.91776657 |
| 35 | MP0010030_abnormal_orbit_morphology | 1.91438146 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.87685976 |
| 37 | MP0004947_skin_inflammation | 1.86788792 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.86305410 |
| 39 | MP0005085_abnormal_gallbladder_physiolo | 1.85859356 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.85840845 |
| 41 | MP0002405_respiratory_system_inflammati | 1.85225478 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.84065523 |
| 43 | MP0001958_emphysema | 1.81691107 |
| 44 | MP0003303_peritoneal_inflammation | 1.80733381 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.78892753 |
| 46 | MP0002398_abnormal_bone_marrow | 1.77974497 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.76287471 |
| 48 | MP0003045_fibrosis | 1.73973828 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.72550946 |
| 50 | MP0000716_abnormal_immune_system | 1.71126251 |
| 51 | MP0003866_abnormal_defecation | 1.70947574 |
| 52 | MP0004272_abnormal_basement_membrane | 1.69756943 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.68548548 |
| 54 | MP0000703_abnormal_thymus_morphology | 1.65655043 |
| 55 | MP0005332_abnormal_amino_acid | 1.58041064 |
| 56 | MP0002060_abnormal_skin_morphology | 1.55415535 |
| 57 | MP0002722_abnormal_immune_system | 1.53501918 |
| 58 | MP0002295_abnormal_pulmonary_circulatio | 1.50878951 |
| 59 | MP0005365_abnormal_bile_salt | 1.50561633 |
| 60 | MP0001873_stomach_inflammation | 1.48166297 |
| 61 | MP0003195_calcinosis | 1.48046094 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.44417288 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.44308253 |
| 64 | MP0004510_myositis | 1.42447346 |
| 65 | MP0005464_abnormal_platelet_physiology | 1.39991602 |
| 66 | MP0000858_altered_metastatic_potential | 1.39264908 |
| 67 | MP0003186_abnormal_redox_activity | 1.37179380 |
| 68 | MP0004084_abnormal_cardiac_muscle | 1.34842523 |
| 69 | MP0002429_abnormal_blood_cell | 1.34661699 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.33840259 |
| 71 | MP0000749_muscle_degeneration | 1.28175546 |
| 72 | MP0000733_abnormal_muscle_development | 1.26278309 |
| 73 | MP0000750_abnormal_muscle_regeneration | 1.24754312 |
| 74 | MP0001851_eye_inflammation | 1.24253455 |
| 75 | MP0004957_abnormal_blastocyst_morpholog | 1.24163493 |
| 76 | MP0005330_cardiomyopathy | 1.22264679 |
| 77 | MP0008469_abnormal_protein_level | 1.21834505 |
| 78 | MP0005508_abnormal_skeleton_morphology | 1.19727481 |
| 79 | MP0002009_preneoplasia | 1.18867999 |
| 80 | MP0005451_abnormal_body_composition | 1.18684227 |
| 81 | MP0001243_abnormal_dermal_layer | 1.17166129 |
| 82 | MP0002269_muscular_atrophy | 1.16333160 |
| 83 | MP0004381_abnormal_hair_follicle | 1.15181516 |
| 84 | MP0005670_abnormal_white_adipose | 1.12671079 |
| 85 | MP0002106_abnormal_muscle_physiology | 1.11500331 |
| 86 | MP0002877_abnormal_melanocyte_morpholog | 1.11476835 |
| 87 | MP0003448_altered_tumor_morphology | 1.11110458 |
| 88 | MP0004233_abnormal_muscle_weight | 1.10079111 |
| 89 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05954650 |
| 90 | MP0000747_muscle_weakness | 1.05421437 |
| 91 | MP0001346_abnormal_lacrimal_gland | 1.04780536 |
| 92 | MP0004019_abnormal_vitamin_homeostasis | 1.04532035 |
| 93 | MP0003091_abnormal_cell_migration | 1.04116116 |
| 94 | MP0001666_abnormal_nutrient_absorption | 1.02500961 |
| 95 | MP0000762_abnormal_tongue_morphology | 1.01869757 |
| 96 | MP0005666_abnormal_adipose_tissue | 1.01513843 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 1.01361175 |
| 98 | MP0000751_myopathy | 1.01082223 |
| 99 | MP0002006_tumorigenesis | 1.00613867 |
| 100 | MP0004087_abnormal_muscle_fiber | 0.99469578 |
| 101 | MP0003252_abnormal_bile_duct | 0.99282956 |
| 102 | MP0010329_abnormal_lipoprotein_level | 0.98896961 |
| 103 | MP0005257_abnormal_intraocular_pressure | 0.97558346 |
| 104 | MP0003693_abnormal_embryo_hatching | 0.94567308 |
| 105 | MP0009250_abnormal_appendicular_skeleto | 0.93643480 |
| 106 | MP0003878_abnormal_ear_physiology | 0.92745164 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.92745164 |
| 108 | MP0003453_abnormal_keratinocyte_physiol | 0.92552434 |
| 109 | MP0002108_abnormal_muscle_morphology | 0.91575679 |
| 110 | MP0008932_abnormal_embryonic_tissue | 0.90448200 |
| 111 | MP0009278_abnormal_bone_marrow | 0.90233834 |
| 112 | MP0004185_abnormal_adipocyte_glucose | 0.89850213 |
| 113 | MP0002138_abnormal_hepatobiliary_system | 0.89003504 |
| 114 | MP0009763_increased_sensitivity_to | 0.88873698 |
| 115 | MP0005395_other_phenotype | 0.88415944 |
| 116 | MP0005310_abnormal_salivary_gland | 0.88346847 |
| 117 | MP0005083_abnormal_biliary_tract | 0.86738172 |
| 118 | MP0005369_muscle_phenotype | 0.86555267 |
| 119 | MP0005166_decreased_susceptibility_to | 0.86429384 |
| 120 | MP0002254_reproductive_system_inflammat | 0.86172923 |
| 121 | MP0003795_abnormal_bone_structure | 0.85875390 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.85690558 |
| 123 | MP0001661_extended_life_span | 0.85372985 |
| 124 | MP0000013_abnormal_adipose_tissue | 0.84345473 |
| 125 | MP0008260_abnormal_autophagy | 0.84029835 |
| 126 | MP0002168_other_aberrant_phenotype | 0.83936880 |
| 127 | MP0003718_maternal_effect | 0.83819994 |
| 128 | MP0009764_decreased_sensitivity_to | 0.82138701 |
| 129 | MP0000609_abnormal_liver_physiology | 0.81962215 |
| 130 | MP0006138_congestive_heart_failure | 0.81507192 |
| 131 | MP0001299_abnormal_eye_distance/ | 0.77311633 |
| 132 | MP0005165_increased_susceptibility_to | 0.76567318 |
| 133 | MP0004130_abnormal_muscle_cell | 0.76081168 |
| 134 | MP0009643_abnormal_urine_homeostasis | 0.75965648 |
| 135 | MP0001348_abnormal_lacrimal_gland | 0.75837196 |
| 136 | MP0000759_abnormal_skeletal_muscle | 0.75716960 |
| 137 | MP0000003_abnormal_adipose_tissue | 0.75277269 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.75035955 |
| 139 | MP0000249_abnormal_blood_vessel | 0.74736392 |
| 140 | MP0000598_abnormal_liver_morphology | 0.73409165 |
| 141 | MP0000377_abnormal_hair_follicle | 0.73043886 |
| 142 | MP0005375_adipose_tissue_phenotype | 0.72620713 |
| 143 | MP0002933_joint_inflammation | 0.72333131 |
| 144 | MP0008775_abnormal_heart_ventricle | 0.72083253 |
| 145 | MP0000627_abnormal_mammary_gland | 0.71953827 |
| 146 | MP0003075_altered_response_to | 0.71597507 |
| 147 | MP0005390_skeleton_phenotype | 0.70870636 |
| 148 | MP0001533_abnormal_skeleton_physiology | 0.69329215 |
| 149 | MP0002796_impaired_skin_barrier | 0.69103860 |
| 150 | MP0001853_heart_inflammation | 0.69085598 |
| 151 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68521137 |
| 152 | MP0000767_abnormal_smooth_muscle | 0.67805000 |
| 153 | MP0004036_abnormal_muscle_relaxation | 0.67763263 |
| 154 | MP0000343_altered_response_to | 0.67428600 |
| 155 | MP0003646_muscle_fatigue | 0.67280394 |
| 156 | MP0002896_abnormal_bone_mineralization | 0.67265817 |
| 157 | MP0000467_abnormal_esophagus_morphology | 0.67186253 |
| 158 | MP0005058_abnormal_lysosome_morphology | 0.64617083 |
| 159 | MP0003828_pulmonary_edema | 0.63532416 |
| 160 | MP0003941_abnormal_skin_development | 0.63496448 |
| 161 | MP0004134_abnormal_chest_morphology | 0.63241753 |
| 162 | MP0009053_abnormal_anal_canal | 0.63071581 |
| 163 | MP0002133_abnormal_respiratory_system | 0.63068677 |
| 164 | MP0005388_respiratory_system_phenotype | 0.63068677 |
| 165 | MP0000163_abnormal_cartilage_morphology | 0.62713911 |
| 166 | MP0002111_abnormal_tail_morphology | 0.61703781 |
| 167 | MP0001544_abnormal_cardiovascular_syste | 0.61458603 |
| 168 | MP0005385_cardiovascular_system_phenoty | 0.61458603 |
| 169 | MP0010630_abnormal_cardiac_muscle | 0.60767837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 6.47289272 |
| 2 | Protrusio acetabuli (HP:0003179) | 5.66097132 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 4.79409953 |
| 4 | Nemaline bodies (HP:0003798) | 4.70288156 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.67211680 |
| 6 | T lymphocytopenia (HP:0005403) | 4.49658397 |
| 7 | Exercise-induced myalgia (HP:0003738) | 4.41869593 |
| 8 | Myositis (HP:0100614) | 4.31703563 |
| 9 | Abnormality of T cell number (HP:0011839) | 4.02482170 |
| 10 | Vertebral compression fractures (HP:0002953) | 3.98763211 |
| 11 | Orchitis (HP:0100796) | 3.90106790 |
| 12 | Optic neuritis (HP:0100653) | 3.78351475 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.78351475 |
| 14 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.51977500 |
| 15 | Ankle contracture (HP:0006466) | 3.48800870 |
| 16 | IgG deficiency (HP:0004315) | 3.37675406 |
| 17 | Muscle fiber splitting (HP:0003555) | 3.35897352 |
| 18 | Biconcave vertebral bodies (HP:0004586) | 3.33833059 |
| 19 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.18501779 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.16711222 |
| 21 | Abnormality of T cells (HP:0002843) | 3.16587446 |
| 22 | Xanthomatosis (HP:0000991) | 3.13754227 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.12169584 |
| 24 | Peritonitis (HP:0002586) | 3.11614147 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.07923629 |
| 26 | Stomatitis (HP:0010280) | 3.07608212 |
| 27 | Increased connective tissue (HP:0009025) | 3.07394191 |
| 28 | EMG: myopathic abnormalities (HP:0003458) | 3.05153965 |
| 29 | Severe combined immunodeficiency (HP:0004430) | 3.04979985 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.03745616 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.03745616 |
| 32 | Abnormal delivery (HP:0001787) | 3.03002391 |
| 33 | Shallow orbits (HP:0000586) | 3.01165182 |
| 34 | Abnormality of eosinophils (HP:0001879) | 2.99848970 |
| 35 | Granulocytopenia (HP:0001913) | 2.99657199 |
| 36 | Hydroxyprolinuria (HP:0003080) | 2.97618942 |
| 37 | Abnormality of proline metabolism (HP:0010907) | 2.97618942 |
| 38 | Abnormality of the umbilical cord (HP:0010881) | 2.97409562 |
| 39 | Pustule (HP:0200039) | 2.96666747 |
| 40 | Cerebral hypomyelination (HP:0006808) | 2.93739458 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.93099024 |
| 42 | Rhabdomyolysis (HP:0003201) | 2.92818388 |
| 43 | Soft skin (HP:0000977) | 2.87678745 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 2.82501884 |
| 45 | Wormian bones (HP:0002645) | 2.82383262 |
| 46 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.82352467 |
| 47 | Hyperglycinuria (HP:0003108) | 2.82013498 |
| 48 | Cervical subluxation (HP:0003308) | 2.80146220 |
| 49 | Gastrointestinal infarctions (HP:0005244) | 2.80019521 |
| 50 | Ileus (HP:0002595) | 2.77924801 |
| 51 | Atrophic scars (HP:0001075) | 2.76111588 |
| 52 | Beaking of vertebral bodies (HP:0004568) | 2.75781650 |
| 53 | Eosinophilia (HP:0001880) | 2.75198573 |
| 54 | Recurrent bacterial skin infections (HP:0005406) | 2.75131054 |
| 55 | Recurrent fungal infections (HP:0002841) | 2.74540424 |
| 56 | Increased IgE level (HP:0003212) | 2.74472789 |
| 57 | Prolonged neonatal jaundice (HP:0006579) | 2.72438736 |
| 58 | Asymmetric septal hypertrophy (HP:0001670) | 2.67016627 |
| 59 | Neck muscle weakness (HP:0000467) | 2.66999808 |
| 60 | Encephalitis (HP:0002383) | 2.66619777 |
| 61 | Broad metatarsal (HP:0001783) | 2.63485847 |
| 62 | Meningitis (HP:0001287) | 2.61133207 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.60604677 |
| 64 | Ulnar deviation of the wrist (HP:0003049) | 2.58744905 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.58554153 |
| 66 | Keratoconjunctivitis sicca (HP:0001097) | 2.57484192 |
| 67 | Hypoalphalipoproteinemia (HP:0003233) | 2.55981354 |
| 68 | Leukocytosis (HP:0001974) | 2.54090559 |
| 69 | Aortic dissection (HP:0002647) | 2.53871605 |
| 70 | Right ventricular cardiomyopathy (HP:0011663) | 2.52974932 |
| 71 | Vasculitis (HP:0002633) | 2.50300927 |
| 72 | Pulmonary infiltrates (HP:0002113) | 2.50074661 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.49800909 |
| 74 | Hyperlipoproteinemia (HP:0010980) | 2.49587886 |
| 75 | Hyperammonemia (HP:0001987) | 2.49206969 |
| 76 | Ragged-red muscle fibers (HP:0003200) | 2.45379479 |
| 77 | Blue sclerae (HP:0000592) | 2.45110835 |
| 78 | Osteolytic defects of the hand bones (HP:0009699) | 2.42776373 |
| 79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.42776373 |
| 80 | Combined immunodeficiency (HP:0005387) | 2.42432109 |
| 81 | Spinal rigidity (HP:0003306) | 2.42330779 |
| 82 | Distal arthrogryposis (HP:0005684) | 2.42062628 |
| 83 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.41906121 |
| 84 | Bulbar palsy (HP:0001283) | 2.41733610 |
| 85 | Increased IgM level (HP:0003496) | 2.40919269 |
| 86 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.40194196 |
| 87 | Hyperglycinemia (HP:0002154) | 2.39345889 |
| 88 | Type 1 muscle fiber predominance (HP:0003803) | 2.38988627 |
| 89 | Colitis (HP:0002583) | 2.38416535 |
| 90 | Breech presentation (HP:0001623) | 2.38283293 |
| 91 | Intrahepatic cholestasis (HP:0001406) | 2.37397929 |
| 92 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36749483 |
| 93 | Obstructive lung disease (HP:0006536) | 2.36749483 |
| 94 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30911706 |
| 95 | Persistence of primary teeth (HP:0006335) | 2.30347576 |
| 96 | Inflammation of the large intestine (HP:0002037) | 2.29501944 |
| 97 | Difficulty climbing stairs (HP:0003551) | 2.26623670 |
| 98 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.24378131 |
| 99 | Recurrent cutaneous fungal infections (HP:0011370) | 2.24378131 |
| 100 | Hypolipoproteinemia (HP:0010981) | 2.24364796 |
| 101 | Recurrent bronchitis (HP:0002837) | 2.23931640 |
| 102 | Gastrointestinal inflammation (HP:0004386) | 2.23840837 |
| 103 | Abnormality of T cell physiology (HP:0011840) | 2.22948840 |
| 104 | Exercise-induced muscle cramps (HP:0003710) | 2.21828053 |
| 105 | Fragile skin (HP:0001030) | 2.21596788 |
| 106 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.20091643 |
| 107 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.20091643 |
| 108 | Single umbilical artery (HP:0001195) | 2.20091643 |
| 109 | Wrist flexion contracture (HP:0001239) | 2.20067152 |
| 110 | Myoglobinuria (HP:0002913) | 2.19073738 |
| 111 | Myocardial infarction (HP:0001658) | 2.18167429 |
| 112 | IgM deficiency (HP:0002850) | 2.17970663 |
| 113 | Dysostosis multiplex (HP:0000943) | 2.17903168 |
| 114 | Recurrent viral infections (HP:0004429) | 2.16911260 |
| 115 | Abnormal cartilage morphology (HP:0002763) | 2.16896196 |
| 116 | Panhypogammaglobulinemia (HP:0003139) | 2.16513050 |
| 117 | Arterial thrombosis (HP:0004420) | 2.16225367 |
| 118 | Cerebral aneurysm (HP:0004944) | 2.13525346 |
| 119 | Chest pain (HP:0100749) | 2.10691773 |
| 120 | Abnormality of serum amino acid levels (HP:0003112) | 2.09709621 |
| 121 | Muscle stiffness (HP:0003552) | 2.09269406 |
| 122 | Aortic aneurysm (HP:0004942) | 2.09170262 |
| 123 | Nonimmune hydrops fetalis (HP:0001790) | 2.07571030 |
| 124 | Increased serum ferritin (HP:0003281) | 2.06762251 |
| 125 | Genu recurvatum (HP:0002816) | 2.06559718 |
| 126 | Gingivitis (HP:0000230) | 2.05971366 |
| 127 | Abnormality of the acetabulum (HP:0003170) | 2.05956691 |
| 128 | Cardiovascular calcification (HP:0011915) | 2.04484766 |
| 129 | Fatigue (HP:0012378) | 2.04277484 |
| 130 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03996823 |
| 131 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03996823 |
| 132 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03996823 |
| 133 | Hemoptysis (HP:0002105) | 2.03694994 |
| 134 | Abnormality of dentin (HP:0010299) | 2.03542587 |
| 135 | Distal lower limb amyotrophy (HP:0008944) | 2.02958457 |
| 136 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.02954369 |
| 137 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01780006 |
| 138 | Dicarboxylic aciduria (HP:0003215) | 2.01780006 |
| 139 | Short nail (HP:0001799) | 2.01501480 |
| 140 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.00741768 |
| 141 | Multiple enchondromatosis (HP:0005701) | 1.99523259 |
| 142 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.99360731 |
| 143 | Urticaria (HP:0001025) | 1.99247958 |
| 144 | Esophageal neoplasm (HP:0100751) | 1.98822858 |
| 145 | Neoplasm of head and neck (HP:0012288) | 1.98822858 |
| 146 | Recurrent skin infections (HP:0001581) | 1.98608267 |
| 147 | Carpal bone hypoplasia (HP:0001498) | 1.98187283 |
| 148 | Autoimmune hemolytic anemia (HP:0001890) | 1.97263105 |
| 149 | Abnormality of the Achilles tendon (HP:0005109) | 1.96433307 |
| 150 | Round ear (HP:0100830) | 1.95793780 |
| 151 | Areflexia of lower limbs (HP:0002522) | 1.94279263 |
| 152 | Lymphopenia (HP:0001888) | 1.93602474 |
| 153 | Deep venous thrombosis (HP:0002625) | 1.93235091 |
| 154 | Anorexia (HP:0002039) | 1.91367995 |
| 155 | Dilatation of the ascending aorta (HP:0005111) | 1.91296466 |
| 156 | Generalized amyotrophy (HP:0003700) | 1.90236192 |
| 157 | Trismus (HP:0000211) | 1.89575747 |
| 158 | Hypobetalipoproteinemia (HP:0003563) | 1.89313656 |
| 159 | Difficulty running (HP:0009046) | 1.89214005 |
| 160 | Achilles tendon contracture (HP:0001771) | 1.87967122 |
| 161 | Polyneuropathy (HP:0001271) | 1.87644330 |
| 162 | Axonal loss (HP:0003447) | 1.87638801 |
| 163 | Elbow flexion contracture (HP:0002987) | 1.87183248 |
| 164 | Hypergammaglobulinemia (HP:0010702) | 1.87152150 |
| 165 | Spontaneous hematomas (HP:0007420) | 1.87106288 |
| 166 | Follicular hyperkeratosis (HP:0007502) | 1.86608944 |
| 167 | Neonatal short-limb short stature (HP:0008921) | 1.86550849 |
| 168 | Knee flexion contracture (HP:0006380) | 1.85393972 |
| 169 | Joint swelling (HP:0001386) | 1.85084464 |
| 170 | Agammaglobulinemia (HP:0004432) | 1.82796134 |
| 171 | Progressive muscle weakness (HP:0003323) | 1.82604314 |
| 172 | Myopathic facies (HP:0002058) | 1.82392282 |
| 173 | Distal lower limb muscle weakness (HP:0009053) | 1.81346540 |
| 174 | Hyperextensible skin (HP:0000974) | 1.79562493 |
| 175 | Ureteral duplication (HP:0000073) | 1.77685060 |
| 176 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77344498 |
| 177 | Bell-shaped thorax (HP:0001591) | 1.76764881 |
| 178 | Hyporeflexia of lower limbs (HP:0002600) | 1.76629511 |
| 179 | Deformed tarsal bones (HP:0008119) | 1.76577700 |
| 180 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.75917598 |
| 181 | Natal tooth (HP:0000695) | 1.74229311 |
| 182 | Cupped ribs (HP:0000887) | 1.74119397 |
| 183 | Calcaneovalgus deformity (HP:0001848) | 1.72355973 |
| 184 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.71923205 |
| 185 | Wide anterior fontanel (HP:0000260) | 1.70784137 |
| 186 | Bladder diverticulum (HP:0000015) | 1.70698111 |
| 187 | Rough bone trabeculation (HP:0100670) | 1.69880684 |
| 188 | Metaphyseal cupping (HP:0003021) | 1.67825938 |
| 189 | Delayed cranial suture closure (HP:0000270) | 1.67556317 |
| 190 | Platyspondyly (HP:0000926) | 1.67437953 |
| 191 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.66326610 |
| 192 | Fused cervical vertebrae (HP:0002949) | 1.65734178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 3.78217934 |
| 2 | MAP4K1 | 3.62386507 |
| 3 | TXK | 3.61935416 |
| 4 | BUB1 | 3.40885280 |
| 5 | BCKDK | 3.32631844 |
| 6 | TESK2 | 3.13977018 |
| 7 | NME2 | 2.86095648 |
| 8 | GRK6 | 2.71030291 |
| 9 | TTN | 2.65882292 |
| 10 | WEE1 | 2.57249820 |
| 11 | MAP3K14 | 2.37446302 |
| 12 | TRIB3 | 2.29813349 |
| 13 | EPHB1 | 2.25906000 |
| 14 | DDR2 | 2.17669269 |
| 15 | FES | 2.03124948 |
| 16 | EIF2AK1 | 2.01478787 |
| 17 | ERN1 | 1.99892160 |
| 18 | ZAP70 | 1.99746624 |
| 19 | RPS6KA4 | 1.97644015 |
| 20 | TAOK3 | 1.93195223 |
| 21 | ZAK | 1.89978024 |
| 22 | SIK1 | 1.86637894 |
| 23 | RIPK4 | 1.84398522 |
| 24 | JAK1 | 1.79527689 |
| 25 | PRPF4B | 1.70888555 |
| 26 | CSK | 1.69323179 |
| 27 | LATS2 | 1.66132465 |
| 28 | IKBKE | 1.65972254 |
| 29 | IRAK4 | 1.65267432 |
| 30 | TYK2 | 1.53253529 |
| 31 | TESK1 | 1.52887849 |
| 32 | MUSK | 1.47258003 |
| 33 | JAK3 | 1.46122632 |
| 34 | MAP3K13 | 1.45898055 |
| 35 | LIMK1 | 1.43137303 |
| 36 | PIM2 | 1.41845842 |
| 37 | PDK2 | 1.41712814 |
| 38 | MET | 1.40741166 |
| 39 | MAP3K11 | 1.38298128 |
| 40 | SIK3 | 1.29127604 |
| 41 | PAK4 | 1.25129884 |
| 42 | BTK | 1.23696224 |
| 43 | SYK | 1.19705349 |
| 44 | MAPK11 | 1.19118493 |
| 45 | STK38L | 1.17459945 |
| 46 | LCK | 1.17027182 |
| 47 | MAP3K3 | 1.15393996 |
| 48 | STK39 | 1.15272118 |
| 49 | RPS6KB2 | 1.14142819 |
| 50 | NEK1 | 1.13739338 |
| 51 | NEK9 | 1.13323408 |
| 52 | PIK3CA | 1.13303583 |
| 53 | ITK | 1.12597166 |
| 54 | PDGFRA | 1.11597578 |
| 55 | PDK3 | 1.10959967 |
| 56 | PDK4 | 1.10959967 |
| 57 | EPHA3 | 1.10575655 |
| 58 | HCK | 1.09948509 |
| 59 | FGFR4 | 1.08923357 |
| 60 | SMG1 | 1.08804140 |
| 61 | MAP3K8 | 1.08329450 |
| 62 | ABL2 | 1.07276181 |
| 63 | MAP3K7 | 1.06403830 |
| 64 | MATK | 1.05571213 |
| 65 | LATS1 | 1.04999722 |
| 66 | TTK | 1.04070277 |
| 67 | BLK | 1.02153426 |
| 68 | MAPK12 | 1.00958781 |
| 69 | NME1 | 1.00338629 |
| 70 | PHKG2 | 0.97165220 |
| 71 | PHKG1 | 0.97165220 |
| 72 | MYLK | 0.96937756 |
| 73 | KIT | 0.96549529 |
| 74 | BRSK2 | 0.95812760 |
| 75 | MST4 | 0.95249244 |
| 76 | TLK1 | 0.93842650 |
| 77 | ILK | 0.93384062 |
| 78 | FER | 0.91594945 |
| 79 | TSSK6 | 0.91468145 |
| 80 | PKN2 | 0.90978436 |
| 81 | DAPK3 | 0.90857481 |
| 82 | MARK3 | 0.90188568 |
| 83 | RIPK1 | 0.90129412 |
| 84 | PAK2 | 0.89060827 |
| 85 | KDR | 0.88804508 |
| 86 | PAK1 | 0.88221297 |
| 87 | PRKCQ | 0.86985166 |
| 88 | TNK2 | 0.84009989 |
| 89 | MAPKAPK3 | 0.83984625 |
| 90 | MAP3K1 | 0.82718744 |
| 91 | MAP2K3 | 0.80951407 |
| 92 | MAPK7 | 0.80212807 |
| 93 | MAP2K2 | 0.79172162 |
| 94 | LRRK2 | 0.78507331 |
| 95 | LYN | 0.78244834 |
| 96 | PRKD2 | 0.76262970 |
| 97 | NUAK1 | 0.75403677 |
| 98 | RPS6KC1 | 0.75242493 |
| 99 | RPS6KL1 | 0.75242493 |
| 100 | PIK3CG | 0.75216319 |
| 101 | EIF2AK3 | 0.74596611 |
| 102 | ARAF | 0.74497810 |
| 103 | MAPKAPK5 | 0.74083008 |
| 104 | CLK1 | 0.70732588 |
| 105 | PTK2 | 0.69495055 |
| 106 | TBK1 | 0.69333087 |
| 107 | TAOK1 | 0.69323791 |
| 108 | PAK3 | 0.68544737 |
| 109 | PRKD1 | 0.67759327 |
| 110 | RPS6KA5 | 0.67307377 |
| 111 | MTOR | 0.65955501 |
| 112 | STK10 | 0.65932629 |
| 113 | TRPM7 | 0.64487448 |
| 114 | CAMK2G | 0.64477699 |
| 115 | RPS6KA6 | 0.64430693 |
| 116 | JAK2 | 0.64356174 |
| 117 | HIPK2 | 0.63297565 |
| 118 | PTK6 | 0.61262154 |
| 119 | RPS6KA2 | 0.60336245 |
| 120 | CDC42BPA | 0.58877556 |
| 121 | MARK2 | 0.58579784 |
| 122 | PDK1 | 0.57602845 |
| 123 | STK3 | 0.57056809 |
| 124 | GSK3A | 0.56173145 |
| 125 | CAMK2D | 0.56020642 |
| 126 | DYRK3 | 0.55732330 |
| 127 | MAPK4 | 0.55423256 |
| 128 | PIM1 | 0.54758719 |
| 129 | AURKA | 0.54638464 |
| 130 | FGFR1 | 0.52857843 |
| 131 | CHUK | 0.52154969 |
| 132 | DMPK | 0.52082311 |
| 133 | PLK1 | 0.51037060 |
| 134 | NLK | 0.50027173 |
| 135 | FGFR2 | 0.49590192 |
| 136 | BMX | 0.49375814 |
| 137 | AURKB | 0.48917254 |
| 138 | PDPK1 | 0.48602240 |
| 139 | BMPR2 | 0.48260265 |
| 140 | ROCK2 | 0.48112300 |
| 141 | NEK2 | 0.47599054 |
| 142 | PRKG2 | 0.47042582 |
| 143 | SCYL2 | 0.46192981 |
| 144 | IRAK1 | 0.45965906 |
| 145 | TGFBR2 | 0.45581685 |
| 146 | SIK2 | 0.44780528 |
| 147 | IRAK3 | 0.44365597 |
| 148 | TEC | 0.44145122 |
| 149 | IKBKB | 0.42404135 |
| 150 | TAOK2 | 0.42310020 |
| 151 | OBSCN | 0.41833697 |
| 152 | PINK1 | 0.41118450 |
| 153 | FGFR3 | 0.40043235 |
| 154 | CDK4 | 0.39671671 |
| 155 | KSR2 | 0.37269576 |
| 156 | PKN1 | 0.36816425 |
| 157 | MAP2K1 | 0.36072878 |
| 158 | RPS6KA1 | 0.35509938 |
| 159 | CDK6 | 0.35422992 |
| 160 | MAP3K6 | 0.34788923 |
| 161 | DYRK1B | 0.34765259 |
| 162 | FLT3 | 0.34241914 |
| 163 | PBK | 0.34237308 |
| 164 | MAPKAPK2 | 0.33212612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.49922502 |
| 2 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.06882662 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.80422892 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.77344803 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.46142380 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.44192012 |
| 7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.42212215 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.41878652 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.41584511 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38265362 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.36433465 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.26218334 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25574465 |
| 14 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.21879684 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.21488185 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.19273241 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.13379364 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 2.10795161 |
| 19 | Measles_Homo sapiens_hsa05162 | 2.07409194 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 2.01949770 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 2.01853354 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.01019779 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.97682576 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.97256462 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91295068 |
| 26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.88937421 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86217544 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.83503989 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.79815624 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77835053 |
| 31 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73242550 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67779924 |
| 33 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65693526 |
| 34 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.63972858 |
| 35 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.63384871 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.62404516 |
| 37 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.62250331 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.61858724 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59338286 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.58285207 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.57996338 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.56691303 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54034015 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.53785809 |
| 45 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.53509663 |
| 46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51158884 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50892438 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.49856445 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.48531102 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.47563436 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.44263162 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43986309 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 1.43861379 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.43754493 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.43166416 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.42927711 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42428194 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41857960 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.38690365 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 1.37468242 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37302661 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.36387696 |
| 63 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32817130 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32549969 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29956927 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 1.29834599 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.29230166 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 1.27369247 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26021470 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22806114 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.22219184 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22134898 |
| 73 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.21559300 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.20468821 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.18285236 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17709466 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16134147 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16108637 |
| 79 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.14993282 |
| 80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.14793150 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.13874216 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13018199 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12153352 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.10668853 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 1.10268714 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.09227398 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 1.08444418 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.07344779 |
| 89 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06996623 |
| 90 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05524132 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.04998962 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03005968 |
| 93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02864761 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.97363498 |
| 95 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96724841 |
| 96 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96209664 |
| 97 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95803808 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.94740756 |
| 99 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.94289960 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93776387 |
| 101 | Lysosome_Homo sapiens_hsa04142 | 0.91381059 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.90947825 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89913502 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.89782958 |
| 105 | RNA polymerase_Homo sapiens_hsa03020 | 0.89015848 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.87402957 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.84811811 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84432993 |
| 109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82162517 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81531843 |
| 111 | Ribosome_Homo sapiens_hsa03010 | 0.80842569 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.80473121 |
| 113 | DNA replication_Homo sapiens_hsa03030 | 0.80270721 |
| 114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.80012878 |
| 115 | RNA transport_Homo sapiens_hsa03013 | 0.78981313 |
| 116 | Legionellosis_Homo sapiens_hsa05134 | 0.78931176 |
| 117 | Pertussis_Homo sapiens_hsa05133 | 0.78320265 |
| 118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77942573 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.75995747 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.74905992 |
| 121 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73427629 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.73308194 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70209137 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69973764 |
| 125 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69796570 |
| 126 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68141657 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.67802815 |
| 128 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.64507025 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64492753 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.62672831 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62539690 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62223526 |
| 133 | Protein export_Homo sapiens_hsa03060 | 0.61184444 |
| 134 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60025169 |
| 135 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59308693 |
| 136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59009948 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58105724 |
| 138 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58081883 |
| 139 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57289239 |
| 140 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.55971989 |
| 141 | Tight junction_Homo sapiens_hsa04530 | 0.54688080 |
| 142 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54535359 |
| 143 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53854001 |
| 144 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52621377 |
| 145 | Amoebiasis_Homo sapiens_hsa05146 | 0.51794675 |
| 146 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51200771 |
| 147 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50720017 |
| 148 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50719277 |
| 149 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49565393 |
| 150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48137235 |
| 151 | Bladder cancer_Homo sapiens_hsa05219 | 0.46678212 |
| 152 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45299541 |
| 153 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45193879 |
| 154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45028515 |
| 155 | Cell cycle_Homo sapiens_hsa04110 | 0.44560832 |
| 156 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44053074 |
| 157 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43114421 |
| 158 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42520914 |
| 159 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42135741 |
| 160 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40916004 |
| 161 | Prion diseases_Homo sapiens_hsa05020 | 0.39882957 |
| 162 | Adherens junction_Homo sapiens_hsa04520 | 0.39697654 |
| 163 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39666123 |
| 164 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39097809 |
| 165 | Mismatch repair_Homo sapiens_hsa03430 | 0.38847965 |
| 166 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38750124 |
| 167 | Insulin resistance_Homo sapiens_hsa04931 | 0.37123579 |
| 168 | Base excision repair_Homo sapiens_hsa03410 | 0.36801955 |
| 169 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36131466 |
| 170 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34487670 |
| 171 | Phagosome_Homo sapiens_hsa04145 | 0.34393585 |
| 172 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31876643 |
| 173 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31752496 |
| 174 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.30940503 |
| 175 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30300727 |
| 176 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29869453 |
| 177 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29397757 |
| 178 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29201604 |
| 179 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26434009 |
| 180 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26006776 |
| 181 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23785070 |
| 182 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22069102 |
| 183 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20014782 |

